Products Categories
  • Mr.Yang
    Tel: +86-21-51623867

  • Mobile:+86-15618786686
  • Tel:+86-21-51623867
  • Fax:+86-21-51623867
  • URL:http://www.rechemscience.com/
  • Province/state:Shanghai
  • City:Shanghai
  • Street:Shanghai
  • MaxCard:
Home > Products >  LDN-212854/ supplier with competitive price in stock-Rechems

LDN-212854/ supplier with competitive price in stock-Rechems CAS NO.1432597-26-6

  • Min.Order: 0
  • Payment Terms:
  • Product Details

Keywords

  • LDN-212854
  • LDN212854
  • 1432597-26-6 manufacturer

Quick Details

  • ProName: LDN-212854/ supplier with competitive ...
  • CasNo: 1432597-26-6
  • Molecular Formula: C??H??N?
  • Application: Medicinal Chemistry 、 Biomedicine、 Pha...
  • DeliveryTime: 1-2days after the payment
  • PackAge: Bottle and bag according to customer
  • Port: Shanghai, Shenzhen
  • Purity: 98%
  • Storage: Stored in well-closed containers
  • Transportation: DHL,UPS,FEDEX EMS or as your request
  • LimitNum: 0

Superiority

1.Custom synthetic service could be provided and COA/HPLC/HNMR is available.
2.Professional synthesis laboratory and production base.
3.Strong synthesis team and service team.
4.Professional data management system.
5.We provide the professional test date and product information.
6.Rich shipping methods,ex. Fedex,DHL,TNT,BY SEA and BY AIR.
7. We can accept various payment methods,Paypal,T/T, etc.
8.Professional packaging can be according the customers’requirment.

Details

LDN-212854 is a novel BMP inhibitor that exhibits substantially greater selectivity for BMP versus the TGF-β type I receptors; possesses a bias towards ALK2(IC50=1.3 nM) versus ALK1 and ALK3 compared to other inhibitors.IC50 value: 1.3 nM Target: ALK2 In vitro, LDN-212854 exhibits some selectivity for ALK2 in preference to other BMP type I receptors, ALK1 and ALK3, which may permit the interrogation of ALK2-mediated signaling, transcriptional activity and function.LDN-212854 potently inhibits heterotopic ossification in an inducible transgenic mutant ALK2 mouse model of fibrodysplasia ossificans progressiva.
Shanghai Rechem science Co., Ltd.
Rechemsis focus on R&D of new APIS, signal transduction inhibitors and pharmaceutical intermediates. We follow closely the industry trend, and the latest research achievements in life science area.
Rechems is located in the largest biomedical base in China--Shanghai and cooperatively established modern production base and laboratory in surrounding areas. We have built up a good relationship with many US / European / Japanese pharmaceutical companies to conduct chemical research and inventory trading in medicinal chemistry.
Rechems's mission is to serve pharmaceutical community by providing excellent services and high-quality products in a timely manner.
Rechems's vision is to be recognized by our clients as one of the best suppliers of chemical products for our superior quality, efficient and cost-effective services.
We insist the principle of "Quality first, customer foremost, best credit, be pioneering and creative", looking forward to establishing good business relationships with customers all over the world. Let's work together for bright future!

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog